1. Home
  2. HTCR vs PPCB Comparison

HTCR vs PPCB Comparison

Compare HTCR & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$1.77

Market Cap

2.7M

Sector

Technology

ML Signal

N/A

Logo Propanc Biopharma Inc.

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.46

Market Cap

2.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
PPCB
Founded
2009
2007
Country
Japan
Australia
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.6M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
HTCR
PPCB
Price
$1.77
$0.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.1K
★ 171.2K
Earning Date
11-17-2026
09-29-2026
Dividend Yield
★ 145.25%
N/A
EPS Growth
★ 414.29
N/A
EPS
★ N/A
N/A
Revenue
★ $30,407,229.00
N/A
Revenue This Year
$118.88
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 39.19
N/A
52 Week Low
$0.15
$0.06
52 Week High
$3.97
$6.79

Technical Indicators

Market Signals
Indicator
HTCR
PPCB
Relative Strength Index (RSI) 29.99 34.52
Support Level N/A $0.17
Resistance Level $2.16 $1.29
Average True Range (ATR) 0.12 0.05
MACD -0.02 0.01
Stochastic Oscillator 19.61 15.59

Price Performance

Historical Comparison
HTCR
PPCB

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: